CB-11 by Cellebrain for Glioblastoma Multiforme (GBM): Likelihood of Approval

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can

The CDC’s vac­cine ad­vi­so­ry pan­el vot­ed 13-1 to rec­om­mend an up­dat­ed Covid-19 boost­er for peo­ple ages 6 months and old­er, a day af­ter the FDA